20250170129. Senotherapeutic Agents Alpha-klotho Polypept (Mayo Foundation for Medical Education and Researc): Difference between revisions
Wikipatents (talk | contribs) Automated patent report |
Wikipatents (talk | contribs) Automated patent report |
||
| Line 22: | Line 22: | ||
<!-- JSON-LD markup for search engines: | <!-- JSON-LD markup for search engines: | ||
{"@context":"https://schema.org","@type":"TechArticle","headline":"20250170129. Senotherapeutic Agents Alpha-klotho Polypept (Mayo Foundation for Medical Education and Researc)","name":"20250170129. Senotherapeutic Agents Alpha-klotho Polypept (Mayo Foundation for Medical Education and Researc)","description":"Patent application abstract and classification for 20250170129 - Senotherapeutic Agents And Alpha-klotho Polypept","datePublished":"2025- | {"@context":"https://schema.org","@type":"TechArticle","headline":"20250170129. Senotherapeutic Agents Alpha-klotho Polypept (Mayo Foundation for Medical Education and Researc)","name":"20250170129. Senotherapeutic Agents Alpha-klotho Polypept (Mayo Foundation for Medical Education and Researc)","description":"Patent application abstract and classification for 20250170129 - Senotherapeutic Agents And Alpha-klotho Polypept","datePublished":"2025-06-01","mainEntity":{"@type":"GovernmentPermit","permitType":"Patent Application","identifier":"20250170129","name":"Senotherapeutic Agents And Alpha-klotho Polypept","additionalProperty":[{"@type":"PropertyValue","name":"Organization","value":"Mayo Foundation for Medical Education and Researc"}]}} | ||
--> | --> | ||
Latest revision as of 14:00, 1 June 2025
SENOTHERAPEUTIC AGENTS AND ALPHA-KLOTHO POLYPEPTIDES
Abstract: this document relates to methods and materials for assessing and/or using one or more senotherapeutic agents. in some cases, methods and materials for determining the efficacy of an anti-senescence treatment in a mammal (e.g., a human) are provided. for example, a level of one or more �-klotho polypeptides in a sample (e.g., a urine sample) from a mammal (e.g., a human) can be used to determine the efficacy of the one or more senotherapeutic agents. in some cases, methods and materials for treating a mammal (e.g., a human) having a disease or disorder characterized by a reduced level of an �-klotho polypeptide are provided. for example, one or more senotherapeutic agents and/or one or more inhibitors of a senescence-associated secretory phenotype (sasp) polypeptide can be administered to a mammal (e.g., a human) to increase a level of �-klotho polypeptides within the mammal.
Inventor(s): Yi Zhu, James L. Kirkland, Tamar Tchkonia, Nino Giorgadze, Tamar Pirtskhalava
CPC Classification: A61K31/506 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))
Search for rejections for patent application number 20250170129